Cytokine profiles in children with primary Epstein-Barr virus infection

Pediatric Blood and Cancer

Volumn 60, Issue 7, 2013, Pages

  Wada, Taizo ^a   Muraoka, Masahiro ^a   Yokoyama, Tadafumi ^a   Toma, Tomoko ^a   Kanegane, Hirokazu ^b   Yachie, Akihiro ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Cytokine; Epstein Barr virus; Hemophagocytic lymphohistiocytosis; Infectious mononucleosis

Indexed keywords

GAMMA INTERFERON; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); EPSTEIN BARR VIRUS INFECTION; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNE RESPONSE; MONONUCLEOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL;

CHILD; CHILD, PRESCHOOL; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; MALE;

EID: 84878258373     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24480     Document Type: Article

References (20)

1. Hislop AD, Taylor GS, Sauce D, et al. Cellular responses to viral infection in humans: Lessons from Epstein-Barr virus. Annu Rev Immunol 2007;25:587-617.
2. Ishii E, Ohga S, Imashuku S, et al. Review of hemophagocytic lymphohistiocytosis (HLH) in children with focus on Japanese experiences. Crit Rev Oncol Hematol 2005;53:209-223.
3. Janka GE. Familial acquired hemophagocytic lymphohistiocytosis. Annu Rev Med 2012;63:233-246.
4. Kasahara Y, Yachie A, Takei K, et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 2001;98:1882-1888.
5. Toga A, Wada T, Sakakibara Y, et al. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis. J Infect Dis 2010;201:1923-1932.
6. Wada T, Kurokawa T, Toma T, et al. Immunophenotypic analysis of Epstein-Barr virus (EBV)-infected CD8(+) T cells in a patient with EBV-associated hemophagocytic lymphohistiocytosis. Eur J Haematol 2007;79:72-75.
7. Ito Y, Kawamura Y, Iwata S, et al. Demonstration of type II latency in T lymphocytes of Epstein-Barr Virus-associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2013;60:326-328.
8. Williams H, Macsween K, McAulay K, et al. Analysis of immune activation and clinical events in acute infectious mononucleosis. J Infect Dis 2004;190:63-71.
9. Wright-Browne V, Schnee AM, Jenkins MA, et al. Serum cytokine levels in infectious mononucleosis at diagnosis and convalescence. Leuk Lymphoma 1998;30:583-589.
10. Attarbaschi T, Willheim M, Ramharter M, et al. T cell cytokine profile during primary Epstein-Barr virus infection (infectious mononucleosis). Eur Cytokine Netw 2003;14:34-39.
11. Tang Y, Xu X, Song H, et al. Early diagnostic and prognostic significance of a specific Th1/Th2 cytokine pattern in children with haemophagocytic syndrome. Br J Haematol 2008;143:84-91.
12. My LT, Lien le B, Hsieh WC, et al. Comprehensive analyses and characterization of haemophagocytic lymphohistiocytosis in Vietnamese children. Br J Haematol 2010;148:301-310.
13. Xu XJ, Tang YM, Song H, et al. Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children. J Pediatr 2012;160:984-990.
14. Shimizu M, Yokoyama T, Yamada K, et al. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford) 2010;49:1645-1653.
15. Yamazaki H, Ohta K, Tsukiji H, et al. Corticosteroid enhances heme oxygenase-1 production by circulating monocytes by up-regulating hemoglobin scavenger receptor and amplifying the receptor-mediated uptake of hemoglobin-haptoglobin complex. Biochem Biophys Res Commun 2007;358:506-512.
16. Ibarra MF, Klein-Gitelman M, Morgan E, et al. Serum neopterin levels as a diagnostic marker of hemophagocytic lymphohistiocytosis syndrome. Clin Vaccine Immunol 2011;18:609-614.
17. Imashuku S, Hibi S, Ohara T, et al. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society. Blood 1999;93:1869-1874.
18. Kanegane H, Wakiguchi H, Kanegane C, et al. Viral interleukin-10 in chronic active Epstein-Barr virus infection. J Infect Dis 1997;176:254-257.
19. Ohta K, Yachie A. Development of vascular biology over the past 10 years: Heme oxygenase-1 in cardiovascular homeostasis. J Endovasc Ther 2004;11:II140-II150.
20. Miyazaki T, Kirino Y, Takeno M, et al. Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions. Int J Hematol 2010;91:229-237.